{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:43:27Z","timestamp":1792100607623,"version":"4.4.0"},"reference-count":31,"publisher":"BMJ","issue":"6632","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1988,5,7]]},"DOI":"10.1136\/bmj.296.6632.1292","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T19:19:55Z","timestamp":1238699995000},"page":"1292-1295","source":"Crossref","is-referenced-by-count":18,"title":["Graves' disease: immunological and immunogenetic indicators of relapse"],"prefix":"10.1136","volume":"296","author":[{"given":"T W A","family":"de Bruin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J H","family":"Bolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Bussemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Stijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G M T","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R R P","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"van der Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0083-6729(08)60485-9","article-title":"Thyroid-stimulating autoantibodies","volume":"38","author":"Adams, D.D.","year":"1980","unstructured":"Adams DD. Thyroid-stimulating autoantibodies. Vitam Horn 1980;38:119-203.","journal-title":"Vitam Horn"},{"key":"ref_2","first-page":"183","article-title":"Immune mechanisms in Graves'","volume":"6","author":"Burman, KD, Baker JR Jr","year":"1985","unstructured":"Burman KD, Baker JR Jr. Immune mechanisms in Graves' disease. EndocrRev 1985;6:183-232.","journal-title":"disease. EndocrRev"},{"key":"ref_3","first-page":"249","article-title":"The thyroid and its diseases","author":"DeGroot, L.J.; Stanbury, J.B.","year":"1975","unstructured":"DeGroot LJ, Stanbury JB. The thyroid and its diseases. 4th ed. New York: John Wiley and Sons, 1975:249-367.","edition":"4th ed"},{"key":"ref_4","first-page":"429","article-title":"Hyperthyroidisn","volume":"Vol","author":"McKenzie, J.M.; Zakarija, M.","year":"1980","unstructured":"McKenzie JM, Zakarija M. Hyperthyroidisn. In: DeGroot L, Cahill GF, Odell WO, et al, eds. Endocrinology. Vol 1. New York: Grune and Stratton, 1980:429-59."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-92-4-488","article-title":"Thionamide therapy in Graves' disease: relation ofrelapse rate to duration of therapy","volume":"92","author":"Tamai, H.; Nakagawa, T.; FukinoO","year":"1980","unstructured":"Tamai H, Nakagawa T, FukinoO, et al. Thionamide therapy in Graves' disease: relation ofrelapse rate to duration of therapy. Ann Intern Med 1980;92:488-90.","journal-title":"Ann Intern Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1210\/edrv-2-1-50","article-title":"The human major histocompatibility complex and endocrine disease","volume":"2","author":"Farid, N.R.; Bear, J.C.","year":"1981","unstructured":"Farid NR, Bear JC. The human major histocompatibility complex and endocrine disease. Endocr Rev 1981;2:50-86.","journal-title":"Endocr Rev"},{"key":"ref_7","first-page":"1101","article-title":"Prediction of relapse in hyperthyroid Graves'","volume":"i:","author":"McGregor, A.M.; Smith, B.R.; Hall, R.; Petersen, M.M.; Miller, M.; Dewar, P.J.","year":"1980","unstructured":"McGregor AM, Smith BR, Hall R, Petersen MM, Miller M, Dewar PJ. Prediction of relapse in hyperthyroid Graves' disease. Lancet 1980;i: 1101-3.","journal-title":"disease. Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem-50-1-144","article-title":"Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drugs and its relationship to relapse: a prospective study","volume":"50","author":"Teng, C.S.; Yeung, R.T.T.","year":"1980","unstructured":"Teng CS, Yeung RTT. Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drugs and its relationship to relapse: a prospective study. 7 Clin Endocrinol Metab 1980;50:144-7.","journal-title":"7 Clin Endocrinol Metab"},{"key":"ref_9","first-page":"719","article-title":"A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype. J7 Clin Endocrinol Metab","volume":"57","author":"Allanic, H.; Fauchet, R.; Lorcy, Y.; Guenquen, M.; Le Guerrier, A.-M.; Genetet, B.","year":"1983","unstructured":"Allanic H, Fauchet R, Lorcy Y, Guenquen M, Le Guerrier A-M, Genetet B. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.J7 Clin Endocrinol Metab 1983;57:719-22."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1986.tb01676.x","article-title":"The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA-status to predict long-term remission of thyrotoxicosis following medical therapy for Graves'","volume":"25","author":"Wilson, R.; McKillop, J.H.; Henderson, N.; Pearson, D.W.; Thomson, J.A.","year":"1986","unstructured":"Wilson R, McKillop JH, Henderson N, Pearson DW, Thomson JA. The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA-status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease. Clin Endocrinol (Oxf) 1986;25: 151-6.","journal-title":"disease. Clin Endocrinol (Oxf)"},{"key":"ref_11","first-page":"409","article-title":"Prediction ofoutcome in Graves' disease after carbimazole treatment","volume":"59","author":"Weetman, A.P.; Ratanachaiyavong, S.; Middleton, G.W.","year":"1986","unstructured":"Weetman AP, Ratanachaiyavong S, Middleton GW, et al. Prediction ofoutcome in Graves' disease after carbimazole treatment. QJ Med 1986;59:409-19.","journal-title":"QJ Med"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-44-1-203","article-title":"Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association","volume":"44","author":"Weiner, S.C.","year":"1977","unstructured":"Weiner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association. 7 Clin Endocrinol Metab 1977;44:203-4.","journal-title":"7 Clin Endocrinol Metab"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(80)92652-5","article-title":"Circulating immune complexes and thyroidstimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves'","volume":"i:","author":"der Heide D, Van; MR, Daha; JH, Bolk","year":"1980","unstructured":"Van der Heide D, Daha MR, Bolk JH, et al. Circulating immune complexes and thyroidstimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease. Lancet 1980;i: 1376-80.","journal-title":"disease. Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00007890-196811000-00006","article-title":"Serotyping for homotransplantation. XVIII. Refinement of microdroplet lymphocyte toxicity test","volume":"6","author":"Mittal, K.D.; Mickey, M.R.; Singal, D.P.; Terasaki, P.I.","year":"1968","unstructured":"Mittal KD, Mickey MR, Singal DP, Terasaki PI. Serotyping for homotransplantation. XVIII. Refinement of microdroplet lymphocyte toxicity test. Transplantation 1968;6:913-27.","journal-title":"Transplantation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/262795a0","article-title":"Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants","volume":"262","author":"JJ, Van Rood; van Leeuwen A; JS, Ploem","year":"1976","unstructured":"Van Rood JJ, van Leeuwen A, Ploem JS. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature 1976;262:795-7.","journal-title":"Nature"},{"key":"ref_16","first-page":"1","article-title":"On estimating the relation between blood group and disease","volume":"25","author":"Woolf, B.","year":"1955","unstructured":"Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:25 1-3.","journal-title":"Ann Hum Genet"},{"issue":"309-1","key":"ref_17","first-page":"1","article-title":"The estimation and significance of the logarithm of a ratio of frequencies","volume":"20","author":"Haldane, J.B.S.","year":"1955","unstructured":"Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1955;20:309-1 1.","journal-title":"Ann Hum Genet"},{"key":"ref_18","first-page":"567","article-title":"HLA and disease susceptibility: clinical implications. C(litcs in Immunology and Allergy","volume":"4","author":"Sveigaard, A.; Platz, B.; Ryder, L.P.","year":"1984","unstructured":"Sveigaard A, Platz B, Ryder LP. HLA and disease susceptibility: clinical implications. C(litcs in Immunology and Allergy. 1984;4:567-80."},{"key":"ref_19","first-page":"2","article-title":"Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentre study","volume":"9","author":"Reinwein, D.; Benker, G.; Konig, M.-P.","year":"1986","unstructured":"Reinwein D, Benker G, Konig M-P, et al. Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentre study. J Endocrinol Invest 1986;9(suppl 2):1-35.","journal-title":"J Endocrinol Invest"},{"key":"ref_20","first-page":"181","article-title":"Value of thyroid-stimulating antibody determinations in predicting short-term thyrotoxic relapse in Graves'","volume":"1","author":"Davies, T.F.; Yeo, P.P.B.; Evered, D.C.; Clark, F.; Smith, B.R.; Hall, R.","year":"1977","unstructured":"Davies TF, Yeo PPB, Evered DC, Clark F, Smith BR, Hall R. Value of thyroid-stimulating antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Lancet 1977;ii: 1 181-2.","journal-title":"disease. Lancet"},{"key":"ref_21","first-page":"770","article-title":"Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. J7 Clin Endocrinol Metab","volume":"46","author":"O'Donnell, J.; Trokoudes, K.; Silverberg, J.; Row, VV, Volpe; R.","year":"1978","unstructured":"O'Donnell J, Trokoudes K, Silverberg J, Row VV, Volpe R. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. J7 Clin Endocrinol Metab 1978;46:770-7."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/acta.0.1110039","article-title":"Goitre size and outcome of medical treatment of Graves'","volume":"111","author":"Laurberg, P.; Hausen, P.E.B.; Iversen, E.; Jensen, S.E.; Weeke, J.","year":"1986","unstructured":"Laurberg P, Hausen PEB, Iversen E, Jensen SE, Weeke J. Goitre size and outcome of medical treatment of Graves' disease. Acta Endocrinol (Copenh) 1986;111: 39-43.","journal-title":"disease. Acta Endocrinol (Copenh)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1210\/jcem-60-1-168","article-title":"Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis","volume":"60","author":"Jansson, R.; Safwenberg, J.; Dahlberg, P.A.","year":"1985","unstructured":"Jansson R, Safwenberg J, Dahlberg PA. Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 1985;60: 168-73.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1530\/acta.0.0860510","article-title":"HLA antigens in Graves'","volume":"86","author":"Bech, K.; Lumholtz, B.; Nerup, J.","year":"1977","unstructured":"Bech K, Lumholtz B, Nerup J, et al. HLA antigens in Graves' disease. Acta Endocrinol (Copenh) 1977;86:510-6.","journal-title":"disease. Acta Endocrinol (Copenh)"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1530\/acta.0.0970042","article-title":"DR antigens in patients with Graves' disease and their correlation with signs and clinical course","volume":"97","year":"1981","unstructured":"Dahlberg PA, Holmlund G, Karlsson EA, Safwenberg J. HLA-A;B;C; and DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Acta Endocrinol (Copenh) 1981;97:42-7.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"ref_26","first-page":"863","article-title":"HLA and Graves'","volume":"51","author":"Allanic, H.; Fauchet, R.; Lorcy, Y.","year":"1980","unstructured":"Allanic H, Fauchet R, Lorcy Y, et al. HLA and Graves' disease: an association with HLA-DRw3. J Clin Endocrinol Metab 1980;51:863-7.","journal-title":"Clin Endocrinol Metab"},{"key":"ref_27","first-page":"111","article-title":"Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity","volume":"ii:","author":"Hanafusa, T.; Pujol-Borrell, R.; Chiovato, L.; Russell, R.C.G.; Doniach, D.; Botazzo, G.F.","year":"1983","unstructured":"Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Botazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983;ii:111-5.","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198701013160104","article-title":"Introduction of circulating activated suppressor-like T cells by methimazole therapy for Graves'","volume":"316","author":"Totterman, T.H.; Karlsson, F.A.; Bengtsson, M.; Mendel-Hartvig, I.","year":"1987","unstructured":"Totterman TH, Karlsson FA, Bengtsson M, Mendel-Hartvig I. Introduction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. N Engl J Med 1987;316: 15-22.","journal-title":"disease. N Engl J Med"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(87)90830-0","article-title":"Protection from autoimmune disease as the third function of the major histocompatibility gene complex","volume":"ii:","author":"Adams, D.D.","year":"1987","unstructured":"Adams DD. Protection from autoimmune disease as the third function of the major histocompatibility gene complex. Lancet 1987;ii:245-9.","journal-title":"Lancet"},{"key":"ref_30","article-title":"Accepted","year":"1987","unstructured":"(Accepted 23 December 1987)"},{"key":"ref_31","article-title":"Abstract Protein was found significantly more frequently in single urine samples from 504 patients with malignancy (290; 58%) than in 529 controls (119; 22%) (p<0001). Median protein concentration was greater (p<0*001) in patients with neoplasia (0.14 g\/l) than in controls (0.07 g\/l). Actuarial analysis showed a median survival of 4*5 months in patients with proteinuria compared with 10 months in those without (p<0 001). The association between proteinuria and shorter survival was statistically significant for patients with gut tumours, lung tumours, and tumours at other sites analysed Renal Unit, St Mary's Hospital, London W2 INY","volume-title":"research registrar MARC WIJNEN, medical student ROGER GABRIEL, MSC, FRCP, renal physician Department of Community Medicine, St Mary's Hospital Medical School, London JANE WADSWORTH, BSC, MSC, lecturer in statistics Correspondence","author":"SAWYER, N.I.C.K.","unstructured":"Abstract Protein was found significantly more frequently in single urine samples from 504 patients with malignancy (290; 58%) than in 529 controls (119; 22%) (p<0001). Median protein concentration was greater (p<0*001) in patients with neoplasia (0.14 g\/l) than in controls (0.07 g\/l). Actuarial analysis showed a median survival of 4*5 months in patients with proteinuria compared with 10 months in those without (p<0 001). The association between proteinuria and shorter survival was statistically significant for patients with gut tumours, lung tumours, and tumours at other sites analysed Renal Unit, St Mary's Hospital, London W2 INY NICK SAWYER, MB, MRCP, research registrar MARC WIJNEN, medical student ROGER GABRIEL, MSC, FRCP, renal physician Department of Community Medicine, St Mary's Hospital Medical School, London JANE WADSWORTH, BSC, MSC, lecturer in statistics Correspondence to: Dr Gabriel."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.296.6632.1292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:53:15Z","timestamp":1601074395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.296.6632.1292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,5,7]]},"references-count":31,"journal-issue":{"issue":"6632","published-print":{"date-parts":[[1988,5,7]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.296.6632.1292","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,5,7]]}}}